Sign In
Buy IQV
$182.05
+1.41 (+0.781%)
At Close: Jun 03, 2026
IQVIA Recognized as Leading eCOA/ePRO Provider in Latest 2020 ISR eCOA/ePRO Market Report
08:00am, Thursday, 04'th Feb 2021
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) today announced that it has been recognized as a top performer by survey respondents in Industry Standard Research'
My Best SaaS Stock for 2021
08:33am, Wednesday, 20'th Jan 2021
Veeva Systems could double its annual revenue over the next four years.
IQVIA Holdings: Upside Potential, Key Levers Overlooked By Sell-Side
12:03pm, Wednesday, 13'th Jan 2021
IQVIA demonstrates a strong sequential growth pattern, in near recovery to pre-pandemic volumes. Management have reinstated the buyback program, with ~$1 billion in authorization, and look set on acqu
Notable Insider Buys Of The Past Week: Danimer Scientific, Cheniere Energy Partners And More
01:49pm, Saturday, 02'nd Jan 2021
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying c
IQVIA and Servier Collaborate to Reinvent Clinical Development
08:00am, Wednesday, 16'th Dec 2020
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sc
IQVIA Supports Collaborative Forum of Top Pharma Leaders to Advance the Use and Acceptance of Real World Evidence
08:00am, Monday, 07'th Dec 2020
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) said today that it is pleased to be a supporter of the Real World Evidence Leadership Forum, a group consisting of
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
03:50pm, Friday, 04'th Sep 2020
Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
Tracking Dan Loeb's Third Point Portfolio - Q2 2020 Update
09:36am, Friday, 28'th Aug 2020
Dan Loeb's 13F portfolio value increased from $6.27B to $7.30B this quarter. The number of positions increased from 30 to 36.
Top Insider Buys Highlight for the Week of August 7
07:04pm, Saturday, 08'th Aug 2020
The largest Insider Buys this week were for Boeing Co., IQVIA Holdings Inc., Schlumberger Ltd. and Elanco Animal Health Inc. Continue reading...
Notable Insider Buys at Allovir, Xerox And Many More
12:00am, Saturday, 08'th Aug 2020
Insider buying can be an encouraging signal for potential investors during periods of uncertainty.
A notable activist investor added to his stake in an old-school tech company....
IQVIA’s Nancy Dreyer and Deepa Desai Honored with 2020 PharmaVOICE Awards
12:00pm, Wednesday, 05'th Aug 2020
IQVIA™ (NYSE: IQV) today announced that Nancy Dreyer, chief scientific officer and senior vice president, Real World Solutions, has been awarded PharmaVOICE magazine’s Red Jacket honor after she w
The vast majority of patients in the United States are experiencing lower out-of-pocket costs for their drugs, paying a smaller share of costs and seeing a downward trend in their costs on average. Th
Insiders Roundup: Tetraphase Pharmaceuticals, Bank of America
03:09pm, Friday, 31'st Jul 2020
Largest insider trades of the week Continue reading...
IQV vs. SSTI: Which Stock Should Value Investors Buy Now?
03:40pm, Thursday, 30'th Jul 2020
IQV vs. SSTI: Which Stock Is the Better Value Option?
IQVIA Launches OCE Optimizer to Help Intelligently Plan HCP Engagements and Maximize Commercial Effectiveness
12:00pm, Wednesday, 29'th Jul 2020
IQVIA™ (NYSE: IQV) today introduced OCE Optimizer, an innovative solution that empowers life sciences companies to plan and refine marketing engagements with healthcare providers (HCPs) on demand. O
